November 6 - 8, 2026
St. Regis San Francisco
125 3rd Street, San Francisco CA 94103
Course Chairs
Uma Mahadevan, MD
Lynne and Marc Benioff Professor of Gastroenterology,
Director, UCSF Colitis and Crohn’s Disease Center
Rishika Chugh, MD
Assistant Professor of Medicine, University of California, San Francisco
Division of Gastroenterology
Fernando Velayos, MD, MPH
Professor of Medicine, University of California, San Francisco
Director of Inflammatory Bowel Disease, Northern California Kaiser
Overview
The UCSF Colitis and Crohn’s Disease Center is dedicated to providing comprehensive care for individuals with Crohn's disease, ulcerative colitis, and related illnesses. As part of this commitment, we are proud to present our twentieth inflammatory bowel disease (IBD) symposium. This course will address advances in the medical and surgical management of Crohn's disease and ulcerative colitis including novel therapies and optimizing current medications. Management of special populations including the pregnant patient and those with complications of therapy will be discussed. This year’s course also includes a workshop on Intestinal Ultrasound for IBD.
Who Should Attend This Course?
This symposium is designed for gastroenterologists, colorectal surgeons, internists, and other health professionals who participate in the management of this complicated patient population.
Objectives
Upon completion of this course, attendees will refine their approaches to:
- Choose appropriate therapy and monitoring for patients with Crohns Disease and Ulcerative Colitis
- Name new mechanisms of treatment for Inflammatory Bowel Disease
- Understand how to treat clostridium dificile colitis
- Understand the unique challenges for older patients with inflammatory bowel disease
- Explain the uses of functional medicine and hyperbaric oxygen therapy for IBD
- Avoid low value care in the patient with inflammatory bowel disease